Bartter Syndrome: A Systematic Review of Case Reports and Case Series.

Mahika Afrin Happy, Rahul Kashyap, Salim Surani, Kaanthi Rama, Shiva Teja Reddy, Piyush Garg, Mohammad Yasir Essar, Gowthami Sai Kogilathota Jagirdhar, Ruman K Qasba, Rakhtan K Qasba, Harshadayani Jagadish Kumar, Faisal A Nawaz, Balakrishnan Kamaraj, Akshat Banga, Pranjal Sharma, Maria Victoria Ferreira Piccoli, Anna Carolina Flumignan Bucharles

Journal: Medicina (Kaunas, Lithuania) 2023;59(9):1638

PMID: 37763757

Abstract

: Bartter syndrome (BS) is a rare group of autosomal-recessive disorders that usually presents with hypokalemic metabolic alkalosis, occasionally with hyponatremia and hypochloremia. The clinical presentation of BS is heterogeneous, with a wide variety of genetic variants. The aim of this systematic review was to examine the available literature and provide an overview of the case reports and case series on BS. : Case reports/series published from April 2012 to April 2022 were searched through Pubmed, JSTOR, Cochrane, ScienceDirect, and DOAJ. Subsequently, the information was extracted in order to characterize the clinical presentation, laboratory results, treatment options, and follow-up of the patients with BS. : Overall, 118 patients, 48 case reports, and 9 case series ( = 70) were identified. Out of these, the majority of patients were male ( = 68). A total of 21 patients were born from consanguineous marriages. Most cases were reported from Asia (73.72%) and Europe (15.25%). In total, 100 BS patients displayed the genetic variants, with most of these being reported as Type III ( = 59), followed by Type II ( = 19), Type I ( = 14), Type IV ( = 7), and only 1 as Type V. The most common symptoms included polyuria, polydipsia, vomiting, and dehydration. Some of the commonly used treatments were indomethacin, potassium chloride supplements, and spironolactone. The length of the follow-up time varied from 1 month to 14 years. : Our systematic review was able to summarize the clinical characteristics, presentation, and treatment plans of BS patients. The findings from this review can be effectively applied in the diagnosis and patient management of individuals with BS, rendering it a valuable resource for nephrologists in their routine clinical practice.

Address: Green Life Medical College and Hospital, Dhaka 1205, Bangladesh.; Department of Medicine, Faculty of Health Sciences, Universidade Positivo, R. Professor Pedro Viriato Parigot de Souza, Curitiba 5300, Brazil.; MercyOne Hospital, Clinton, IA 52732, USA.; Sawai Man Singh Medical College, Jaipur 302004, Rajasthan, India.; Madurai Medical College, Madurai 625020, Tamil Nadu, India.; Emirates Health Services, Al Amal Psychiatric Hospital, Dubai 345055, United Arab Emirates.; Sapthagiri Institute of Medical Sciences, Banglore 560090, Karnataka, India.; Sher-I-Kashmir Institute of Medical Sciences, Srinagar 190001, Jammu and Kashmir, India.; Department of Medicine, Saint Michaels Medical Center, Newark, NJ 07102, USA.; Department of Global Health, McMaster University, Hamilton, ON L8S 4L8, Canada.; JJM Medical College, Davanagere 577004, Karnataka, India.; Gandhi Medical College, Secunderabad 500025, Telangana, India.; Department of Medicine & Pharmacology, Texas A&M University, College Station, TX 79016, USA.; Critical Care Medicine, Department of Anesthesiology, Mayo Clinic, Rochester, MN 55905, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.